Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS MODIFICATION IS TO EXTEND CLIN0001/BASE THROUGH DECEMBER 31, 2026, PROVIDE SUPPLEMENTAL FUNDING TO SUPPORT THE DEVELOPMENT OF INTRAMUSCULAR (IM) ENA-001 FOR SUBMISSION TO THE US FOOD AND DRUG ADMINISTRATION, UPDATE SECTION I.1 FED
ENALARE THERAPEUTICS INC · Department of Health and Human Services
- Value
- $12,209,278
- Start
- Sep 22, 2022
- End
- Dec 31, 2026
- Action date
- May 18, 2026
- PIID
- 75A50122C00072
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- PRINCETON, NJ
- Award type
- DEFINITIVE CONTRACT
Description
THE PURPOSE OF THIS MODIFICATION IS TO EXTEND CLIN0001/BASE THROUGH DECEMBER 31, 2026, PROVIDE SUPPLEMENTAL FUNDING TO SUPPORT THE DEVELOPMENT OF INTRAMUSCULAR (IM) ENA-001 FOR SUBMISSION TO THE US FOOD AND DRUG ADMINISTRATION, UPDATE SECTION I.1 FED
Need modifications, related awards, and vendor peers? Open the full award workspace.